Stanley Druckenmiller: portfolio of Duquesne Family Office
Stanley Druckenmiller manages his own wealth through the Duquesne Family Office; earlier he ran the macro fund Duquesne Capital.
Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 3.0B USD
- Positions
- 49
- Share of the ten largest
- 61.4%
The ten largest positions Q1 2025
- Natera Inc 16.1%▼ −4.6%
- Teva Pharmaceutical Inds Ltd 7.7%▲ +65.4%
- Coupang Inc 6.8%▲ +4.5%
- Woodward Inc 6.7%▼ −10.4%
- Philip Morris International 5.9%▼ −18.3%
- Coherent Corp. 4.8%▼ −21.2%
- MercadoLibre 3.5%unchanged
- Insmed Inc 3.5%▲ +130.7%
- Taiwan Semiconductor Manufacturing (ADR) 3.3%▲ +456.9%
- Docusign Inc 2.9%new
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Natera Inc | 16.1% | 3,402,330 | 481.1M USD | −4.6% reduced | Q3 2022 11 quarters |
| Teva Pharmaceutical Inds Ltd | 7.7% | 14,879,750 | 228.7M USD | +65.4% increased | Q3 2024 3 quarters |
| Coupang Inc | 6.8% | 9,302,634 | 204.0M USD | +4.5% increased | Q1 2021 17 quarters |
| Woodward Inc | 6.7% | 1,097,750 | 200.3M USD | −10.4% reduced | Q4 2023 6 quarters |
| PM Philip Morris International | 5.9% | 1,105,268 | 175.4M USD | −18.3% reduced | Q2 2024 4 quarters |
| COHR Coherent Corp. | 4.8% | 2,222,070 | 144.3M USD | −21.2% reduced | Q1 2024 5 quarters |
| MELI MercadoLibre | 3.5% | 53,725 | 104.8M USD | unchanged | Q2 2024 4 quarters |
| Insmed Inc | 3.5% | 1,369,050 | 104.4M USD | +130.7% increased | Q2 2024 4 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 3.3% | 598,780 | 99.4M USD | +456.9% increased | Q3 2024 3 quarters |
| Docusign Inc | 2.9% | 1,074,655 | 87.5M USD | new | Q1 2025 1 quarter |
| Flutter Entmt Plc | 2.8% | 377,475 | 83.6M USD | +1,985.5% increased | Q2 2024 4 quarters |
| LLY Lilly (Eli) | 2.6% | 94,830 | 78.3M USD | +52.5% increased | Q4 2024 2 quarters |
| Ypf Sociedad Anonima | 2.4% | 2,075,390 | 72.7M USD | +23.0% increased | Q2 2024 4 quarters |
| Verona Pharma Plc | 2.1% | 1,002,080 | 63.6M USD | +12.9% increased | Q3 2024 3 quarters |
| Barclays Plc | 2.0% | 3,817,305 | 58.6M USD | +19.8% increased | Q1 2024 5 quarters |
| WAB Wabtec | 1.8% | 301,095 | 54.6M USD | +7.5% increased | Q1 2024 5 quarters |
| Ccc Intelligent Solutions Hl | 1.7% | 5,595,039 | 50.5M USD | new | Q1 2025 1 quarter |
| KMI Kinder Morgan | 1.6% | 1,654,115 | 47.2M USD | −25.7% reduced | Q1 2024 5 quarters |
| EQT EQT Corporation | 1.5% | 859,345 | 45.9M USD | new | Q1 2025 1 quarter |
| Caesars Entertainment Inc Ne | 1.3% | 1,548,420 | 38.7M USD | new | Q1 2025 1 quarter |
| FCX Freeport-McMoRan | 1.3% | 1,018,105 | 38.5M USD | +34.2% increased | Q4 2023 6 quarters |
| Daktronics Inc | 1.3% | 3,067,625 | 37.4M USD | +16.9% increased | Q1 2024 5 quarters |
| Global X Fds | 1.2% | 443,800 | 35.8M USD | −19.1% reduced | Q1 2024 5 quarters |
| TWLO Twilio | 1.2% | 362,155 | 35.5M USD | new | Q1 2025 1 quarter |
| COF Capital One | 1.2% | 197,670 | 35.4M USD | new | Q1 2025 1 quarter |
| Roku Inc | 1.2% | 493,600 | 34.8M USD | new | Q1 2025 1 quarter |
| Banco Macro Sa | 1.1% | 431,815 | 32.6M USD | −11.0% reduced | Q1 2024 5 quarters |
| Springworks Therapeutics Inc | 0.9% | 615,929 | 27.2M USD | −28.4% reduced | Q2 2024 4 quarters |
| AMZN Amazon | 0.9% | 136,765 | 26.0M USD | −58.4% reduced | Q4 2024 2 quarters |
| UAL United Airlines Holdings | 0.9% | 368,685 | 25.5M USD | −64.7% reduced | Q4 2024 2 quarters |
| Ascendis Pharma A/S | 0.8% | 158,720 | 24.7M USD | −40.1% reduced | Q3 2024 3 quarters |
| Purecycle Technologies Inc | 0.8% | 3,364,842 | 23.3M USD | +111.3% increased | Q4 2024 2 quarters |
| Grupo Financiero Galicia S.A | 0.7% | 381,481 | 20.8M USD | −15.0% reduced | Q1 2024 5 quarters |
| Seagate Technology Hldngs Pl | 0.6% | 219,477 | 18.6M USD | −86.0% reduced | Q3 2023 7 quarters |
| Brookfield Corp | 0.6% | 315,925 | 16.6M USD | −48.2% reduced | Q4 2024 2 quarters |
| Newamsterdam Pharma Company | 0.5% | 800,360 | 16.4M USD | +178.4% increased | Q3 2024 3 quarters |
| Teck Resources Ltd | 0.5% | 431,545 | 15.7M USD | unchanged | Q1 2022 13 quarters |
| Bridgebio Pharma Inc | 0.5% | 438,050 | 15.1M USD | new | Q1 2025 1 quarter |
| DAL Delta Air Lines | 0.5% | 345,135 | 15.0M USD | −57.8% reduced | Q4 2024 2 quarters |
| FLEX Flex Ltd. | 0.4% | 348,900 | 11.5M USD | unchanged | Q4 2023 6 quarters |
| EXE Expand Energy | 0.4% | 97,700 | 10.9M USD | new | Q1 2025 1 quarter |
| APP AppLovin | 0.4% | 40,200 | 10.7M USD | new | Q1 2025 1 quarter |
| Antero Resources Corp | 0.4% | 258,400 | 10.5M USD | new | Q1 2025 1 quarter |
| Impinj Inc | 0.3% | 108,475 | 9.8M USD | new | Q1 2025 1 quarter |
| TSLA Tesla, Inc. | 0.2% | 18,838 | 4.9M USD | −50.0% reduced | Q4 2024 2 quarters |
| Ultragenyx Pharmaceutical In | 0.1% | 85,445 | 3.1M USD | unchanged | Q3 2024 3 quarters |
| American Airl | < 0.1% | 133,728 | 1.4M USD | −85.5% reduced | Q4 2024 2 quarters |
| Invivyd Inc | < 0.1% | 571,425 | 346.0K USD | unchanged | Q2 2024 4 quarters |
| JOBY Joby Aviation | < 0.1% | 31,489 | 190.0K USD | unchanged | Q3 2022 11 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 3 option positions, value of the underlying shares as reported 77.9M USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- Delta Air Lines Call 41.4M USD
- Seagate Technology Hldngs Pl Call 20.9M USD
- United Airlines Holdings Call 15.6M USD
Breakdown by sector
- Technology 9.7%
- Consumer Staples 5.9%
- Energy 3.5%
- Industrials 3.2%
- Health Care 2.6%
- Materials 1.3%
- Financials 1.2%
- Consumer Discretionary 1.0%
- Communication Services 0.4%
- not in our coverage 71.2%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors